Our results (shown in Fig. 4 and Supplementary Fig. 4) demonstrate DUB3's ability to increase breast cancer cell migration and metastasis by targeting SNAIL1, thereby supporting our hypothesis that DUB3 promotes breast carcinoma metastasis in patients. Here, USP17L2 is linked to breast cancer.